Loading...

PODCAST

Lung Cancer Considered

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association"s membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The

science

All Episodes

00:45:30

LCC in Korean WCLC 2026 Highlights

Lung Cancer Considered ·

2026/10/06

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.In this episode, host Dr. Chul Kim moderates a discussion in Korean about breakthrough advances in thoracic oncology presented at the conference with Dr. Ji-Youn Han, Dr. Tae Min Kim, and Dr. Sehhoon Park. Guests: Ji-Youn Han, MD,

en

00:24:36

WCLC 2026 Patient Advocate Takeover: Centering...

Lung Cancer Considered ·

2026/10/05

In this special Patient Advocate Takeover episode, recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, patient advocates Dr. Sydney Barned and Yvonne Diaz discuss the research and conversations that caught their attention at the meeting. They reflect on access to new therapies, the importance of involving patient advocates early in clinical trial design, and how stronger communication between patients and providers can improve care. Plus, hear what they look for in new research

en

00:34:01

WCLC 2026 East-West Academic Exchange: Collaborating...

Lung Cancer Considered ·

2026/10/01

Recorded live at the IASLC World Conference on Lung Cancer (WCLC) 2026 in Seoul, this episode brings together experts from China and the U.S. to discuss the growing exchange of ideas, research, and clinical expertise between the regions. Dr. Chul Kim, Dr. Stephen Liu, Dr. Yuanyuan Zhao, and Dr. Caicun Zhou discuss key research highlights presented at WCLC and explore why lung cancer research is advancing rapidly in China, plus how stronger global collaboration can shape the future of thoracic

en

00:44:28

WCLC 2026 Nurse Practitioner Takeover: What APPs are...

Lung Cancer Considered ·

2026/09/29

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Nurse Practitioner takeover episode looks at key developments in small cell lung cancer, antibody-drug conjugates, and lung cancer screening — with a focus on what APPs can take back to the clinic. Laura Macke, Stephanie McDonald, and Dr. Mary Pasquinelli discuss the studies and advances that caught their attention, including how these developments will affect patient conversations, treatment decisions, and the

en

00:10:59

LCC in Czech: WCLC 2026 Highlights

Lung Cancer Considered ·

2026/09/24

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Marie Drösslerová moderates a discussion in Czech about breakthrough advances in thoracic oncology presented at the conference with Dr. Fernando Casas Mendez and Dr. Martin Svaton. Guests: Marie Drösslerová,

en

00:48:55

LCC in Spanish: WCLC 2026 Highlights

Lung Cancer Considered ·

2026/09/17

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Narjust Florez moderates a discussion in Spanish about breakthrough advances in thoracic oncology presented at the conference with Dr. Jorge Alatorre Alexander and Dr. Miguel Gonzalez Velez. Guests: Jorge

en

00:29:00

LCC in Portuguese: WCLC 2026 Highlights

Lung Cancer Considered ·

2026/09/17

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Clarissa Mathias moderates a discussion in Portuguese about breakthrough advances in thoracic oncology presented at the conference with Dr. Lilian Faroni and Dr. Vladmir Cordeiro de Lima. Guests: Lilian Faroni,

en

00:44:37

Live From WCLC 2026: Tuesday Highlights & Meeting...

Lung Cancer Considered ·

2026/09/15

In this special WCLC 2026 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu recap key findings from day three of the conference, featuring major advances that move targeted therapies earlier in the treatment of lung cancer. Guests Dr. Julia Rotow, Dr. Roy Herbst, and Dr. Daniel Tan discuss new data from DESTINY-Lung04, ADAURA, and REZILIENT3 and what these findings could mean for clinical practice. Guests: Dr. Julia Rotow Clinical Director and Research Director,

en

00:37:12

LCC in Mandarin: WCLC 2026 Highlights

Lung Cancer Considered ·

2026/09/15

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Chunxia Su moderates a discussion in Mandarin Chinese about breakthrough advances in thoracic oncology presented at the conference with Dr. Zhengfei Zhu, Dr. Yun Fan, and Dr. Dongsheng Yue. Guests: Dr. Yun Fan,

en

00:31:18

Live From WCLC 2026: Monday Highlights

Lung Cancer Considered ·

2026/09/14

In this special WCLC 2026 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference and ask what changes in clinic on Monday. A ROS1 drug that protects the brain and a first line combination that could not beat a decade old standard. Dr. Alexander Drilon brings the first line ARROS-1 data on zidesamtinib, and Dr. Giannis Mountzios walks us through EVOKE-03, sacituzumab govitecan plus pembrolizumab in PD-L1 high lung cancer.

en

00:47:07

Live From WCLC 2026: Sunday Highlights

Lung Cancer Considered ·

2026/09/14

From the IASLC 2026 World Conference on Lung Cancer (WCLC) in Seoul, Dr. Narjust Florez talks with Dr. Chad Rusthoven about MAVERICK, the trial that tested MRI surveillance alone against prophylactic cranial irradiation in small cell lung cancer, and with Dr. Chul Kim about the final overall survival results of PAPILLON, amivantamab plus chemotherapy in EGFR exon 20 insertion NSCLC. Both guests share what patients and community oncologists should take from the data. Guests: Chul Kim, MD, MPH

en

00:38:27

Before You Go: A Practical Guide to WCLC 2026 in Seoul

Lung Cancer Considered ·

2026/09/04

Get ready for WCLC 2026 in Seoul with Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Florez. From preparing for the flight and beating jet lag to navigating COEX, networking, exploring Seoul’s food scene, and making the most of the meeting, they share practical tips to help attendees arrive prepared and enjoy the full WCLC experience.

en

00:47:30

Beyond Stage IV: Rethinking Oligometastatic Lung Cancer

Lung Cancer Considered ·

2026/09/01

In this episode, Dr. Narjust Florez is joined by Dr. Yasir Elamin and Dr. Liliana Faroni to explore the evolving management of oligometastatic lung cancer. They break down key definitions, discuss when and how to use consolidative therapies like radiation and surgery, and examine patient selection, limitations, and emerging tools such as ctDNA that are shaping a more precise approach to care.Guests: Yasir Elamin, MD Associate Professor of Thoracic Medical University of Texas MD Anderson Cancer

en

00:46:42

LCC in Korean: The Role of Immunotherapy in Lung Cancer

Lung Cancer Considered ·

2026/08/28

In this Korean-language episode of Lung Cancer Considered, Dr. Chul Kim is joined by Dr. Hye-Ryun Kim and Dr. Young Kwang Chae to discuss the evolving role of immunotherapy across the lung cancer treatment continuum. They explore perioperative strategies for resectable NSCLC, treatment selection and biomarkers in advanced disease, emerging research, and what they are looking forward to at WCLC 2026 in Seoul.Guest Host: Chul Kim, MD, MPH Thoracic Medical Oncologist and Associate Professor

en

00:29:24

The Global Fight Against Lung Cancer: A Conversation...

Lung Cancer Considered ·

2026/08/25

Host Dr. Stephen Liu is joined by José Luis Castro, WHO Director-General Special Envoy for Chronic Respiratory Diseases, for a thought-provoking discussion on why lung cancer must be recognized as a global health priority. They explore the challenges of raising awareness, reducing stigma, expanding equitable access to lung cancer screening and care, and advancing the policies and partnerships needed to improve outcomes worldwide. The conversation also offers a preview of Castro's keynote message

en

00:47:14

LCC: Grace Under Pressure: Navigating Burnout and...

Lung Cancer Considered ·

2026/08/18

In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Mark Lewis and Dr. Michael Maddaus for a candid conversation about physician wellness, burnout, grief, and resilience. Drawing from their personal and professional experiences, they explore the hidden emotional toll of caring for patients with cancer, the limitations of the “just be more resilient” mindset, and the importance of self-compassion, vulnerability, and seeking support.Dr. Mark Lewis is Director of

en

00:46:26

LCC Advances in ALK+ Cancer in Cantonese

Lung Cancer Considered ·

2026/08/14

As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with Dr. Tony Mok, Dr. Chao Zhang, and Dr. Wen-Zhao Zhong. The discussion reviews advances in ALK+ non-small cell lung cancer (NSCLC).

en

00:59:23

Treating Advanced Thymic Cancers

Lung Cancer Considered ·

2026/08/04

Thymic epithelial tumors are rare but complex thoracic cancers that require specialized diagnosis and multidisciplinary management. In this episode of Lung Cancer Considered, Dr. Stephen Liu is joined by Dr. Nicolas Girard and Dr. Erica Pietroluongo to discuss the diagnosis, staging, and treatment of thymoma and thymic carcinoma, including current standards of care, evolving systemic therapies, and promising areas of research. They also highlight the importance of international collaboration in

en

00:24:01

FDA Approval: Zidesamtinib and ROS1 NSCLC

Lung Cancer Considered ·

2026/07/28

Patients with ROS1-positive NSCLC have a new treatment option following the FDA approval of zidesamtinib for those previously treated with a ROS1 tyrosine kinase inhibitor. In this episode, Dr. Stephen Liu, Dr. Alexander Drilon, and Dr. Rosario Charo Garcia Campelo discuss the ARROS1 trial results, the drug's efficacy and safety profile, CNS activity, and where zidesamtinib may fit into current and future treatment strategies for ROS1-positive lung cancer.Guests: Alexander Drilon, MD Chief, Early

en

00:47:39

Rewriting the Playbook: Cellular Therapy and Vaccines...

Lung Cancer Considered ·

2026/07/21

How could cellular therapies and cancer vaccines transform the future of treatment for ALK-positive lung cancer? Host Dr. Narjust Florez sits down with Dr. Vincent Lam and Dr. Carmen Mecca to explore the latest research, the science driving these innovative approaches, and what these advances could mean for patients and the future of precision oncology.Key Topics Covered: • ALK-positive lung cancer • Cellular Therapy • Vaccines Guests: Vincent Lam, MD Associate Professor of Oncology, Johns

en

415 results

Similar Podcasts

Science Weekly

The Guardian

La Science CQFD

France Culture

The Dirt: an eKonomics podKast

eKonomics

La Science, CQFD

France Culture

Travelers In The Night

Albert D. Grauer